Delivery Order SPE2DB22D1106-SPE2DB25FDZV8
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,574.56, is a Firm Fixed Price Delivery Order for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,171.60 delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty medication. The contract has an ultimate completion date of October 15, 2024 and uses a firm fixed price pricing type. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,819.58 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a prescription medication. The contract has an ultimate completion date of September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,242.80, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The $7,929.00 fixed-price contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, through its Corporate Office division, is a significant supplier of medical commodities to the U.S. federal government, including military treatment facilities and veterans'...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,361.44, is for the delivery of 4566958613 ! OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a performance period through January 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.52 firm fixed-price delivery order covers the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a period of performance through September 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The firm-fixed-price contract has a ceiling value of $3,171.60 and a completion date of February 16, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.15 firm fixed price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. AmerisourceBergen holds two relevant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
This federal contract award to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, is a $5,814.60 firm fixed-price delivery order from the Defense Logistics Agency (DLA) for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a medication. The contract has a period of performance through June 27, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical,...